Where innovation meets
Medical Impact
We identify, incubate, and marketplace connect high-potential medical product candidates (MPCs) across the innovation lifecycle, leveraging proprietary AI to accelerate breakthroughs from research to market.
What is a Medical Product Candidate?
The foundation of our AI-powered drug development platform
A Medical Product Candidate (MPC) represents a comprehensive package of research, data, and strategic planning that transforms raw scientific discoveries into viable pharmaceutical products ready for development and commercialization.
Research Foundation
Clinical trial data, scientific evidence, and validated therapeutic mechanisms
Regulatory and R&D Strategy
eCTD documentation, regulatory pathways, and approval strategies
Commercial Readiness
Market analysis, IP protection, manufacturing strategy, and partnership framework
Financial Modeling
Development costs, market projections, and ROI analysis
From Research to Market
Our AI platform transforms fragmented research into comprehensive MPCs that pharmaceutical companies can immediately evaluate and develop, reducing time-to-market by years.
Our Technology Platform
Three interconnected AI systems that redefine how research assets are sourced, evaluated, refined, and partnered
Intelligence
We're revolutionizing MPC discovery with AI that predicts and synthesizes viable products from global clinical trials.
Our MPC Analyzer uses an ETL pipeline to normalize and enrich trial data with metadata on diseases, modalities, IP, manufacturing, success probabilities, and more. Powered by LLMs and multi-agent systems, it generates hypotheses, auto-screens for FTO, feasibility, regulatory leverage, and market fit, then proactively onboards top candidates via marketplace integration.
Evidence Graph & Enrichment
Unified database of worldwide trials, enriched for targeted searches, novelty assessment, and predictive success modeling.
Multi-Agent Hypothesis & Screening
Synthesize MPC ideas from clinical evidence, rank by FTO, manufacturability, regulatory paths, and commercial potential.
Incubation
We're creating a collaborative incubation environment that bridges AI automation with human expertise to transform raw research into viable medical products.
Our MPC Incubator works in tandem with the Shrare team (humans-in-the-loop) to refine and advance candidates through key milestones. This includes combining complementary research streams, adjusting evidence for compelling MPCs, and generating comprehensive plans for approval.
MPC Identification & Refinement
Identify final product candidates by merging multiple research elements or tweaking original studies to build strong evidence bases for approval.
R&D Strategy & Success Modeling
Develop detailed plans from current states to market entry, including probability-of-success forecasts, timelines, and optimized pathways.
Regulatory Tools
Automate eCTD documentation, IND submissions, and regulatory program applications.
Financial Tools
Perform financial modeling for approval costs and post-market projections.
Partner Matching & Ecosystem Search
Algorithmically identify and prioritize optimal collaborators—such as manufacturers, patient associations, CROs, and pharma companies (pharma, foundations)—based on alignment and interest.
Marketplace
We're building an AI-driven marketplace that streamlines connections between researchers, pharma companies, and the broader community, making collaboration seamless and insights actionable.
Our AI Marketplace facilitates easy onboarding of research, real-time progress updates, and interactive feedback loops to enhance decision-making. It empowers pharma companies with intuitive tools for due diligence while collecting community input to refine AI models through RLHF and fine-tuning.
Researcher Onboarding & Progress Tracking
Allow researchers to upload documentation effortlessly, receive automated updates on advancements, and respond to targeted prompts from Shrare for specialized feedback.
Pharma Due Diligence & Visualization
Provide fast, reliable tools like interactive charts, visualizations, and chat-based RAG systems for thorough evaluations and informed decisions.
Community Feedback & AI Enhancement
Gather insights from researchers, pharma companies, and the ecosystem to improve platform features, with data used for RLHF, fine-tuning AI agents, and optimizing workflows.
Seamless Integration
Our three technology pillars work together to create a unified, intelligent drug development ecosystem
Intelligence
AI discovers and evaluates promising research from global clinical trials
Incubation
Transforms raw research into comprehensive, market-ready medical products
Marketplace
Connects refined MPCs with pharmaceutical partners and pharma companies
Experience the Future of Drug Development
Join the revolution in pharmaceutical innovation. Whether you're a researcher with groundbreaking discoveries or a pharma company seeking the next breakthrough, our AI-powered platform is designed to accelerate your success.